QS21

QS-21 is a saponin derived from the bark of the Quillaja saponaria tree, commonly known as the soap bark tree. It is used as an adjuvant in vaccines to enhance the body's immune response to an antigen. QS-21 has been used in vaccines for diseases such as malaria, HIV, and cancer.

History[edit | edit source]

QS-21 was first isolated from the bark of the Quillaja saponaria tree in the 1960s. It was initially used in veterinary vaccines, but its potential for use in human vaccines was soon recognized. The first human trials of QS-21 began in the 1990s.

Mechanism of Action[edit | edit source]

QS-21 works by stimulating the body's immune system to produce a stronger response to an antigen. It does this by activating immune cells such as T cells and B cells, which are responsible for recognizing and attacking foreign substances in the body.

Use in Vaccines[edit | edit source]

QS-21 has been used in a number of vaccines, including those for malaria, HIV, and cancer. It is often combined with other adjuvants to enhance its effectiveness. For example, in the Shingrix vaccine for shingles, QS-21 is combined with another adjuvant called MPL.

Safety and Side Effects[edit | edit source]

While QS-21 is generally considered safe, it can cause side effects in some people. These can include pain and swelling at the injection site, fever, and headache. In rare cases, severe allergic reactions can occur.

Future Research[edit | edit source]

Research is ongoing into the potential uses of QS-21 in other vaccines. It is also being studied for its potential use in treatments for allergies and autoimmune diseases.

See Also[edit | edit source]

QS21 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.